Search

Kidney disease has reached epidemic proportions in the U.S. The Carroll Lab performs basic and translational research focused on kidney development, maintenance and regeneration. 

Skip to main content Research Dr. Zheng’s primary research interests Type II endometrial carcinogenesis Dr. Zheng is one of the world's pioneer investigators for this area. In the last 12 years, together with colleagues, collaborators, and trainees, Dr. Zheng has defined the precancer lesions and lat…

Skip to main content Publications Laterality and Sex Differences of Human Lateral Habenula Afferent and Efferent Fiber Tracts. Hitti FL, Parker D, Yang AI, Brem S, Verma R, 2022 Front Neurosci 16 837624 Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression:…

Skip to main content People Meet the Principal Investigator Frederick Hitti, M.D., Ph.D. Frederick Hitti, M.D., Ph.D., is an Assistant Professor in the Departments of Neurological Surgery and Psychiatry at UT Southwestern Medical Center. Clinically, he specializes in epilepsy and movement disorders, …

Skip to main content Cell Origin of Ovarian Carcinoma Until recently, the incessant ovulation theory put forward by Fathalla in 1971 has been the most widely accepted theory of ovarian carcinogenesis [1]. According to this theory, constant ovulation-induced damage and repair of the ovarian surface ep…

The Bowen Lab focuses on the development of hybrid positron emission tomography (PET) (e.g. PET-CT and PET-MR) tools to enable precision imaging for the care and study of oncology, neurology, and cardiology patients.

Skip to main content Join Us We are always looking for highly motivated people to join our research team or collaborate with us. We are committed to better understanding the brain circuits implicated in treatment resistant depression with the ultimate goal of developing novel therapies. If you are in…

Research in the Rothermel Laboratory focuses on deciphering the molecular mechanisms that control cardiac structure and function during normal development and in response to pathological stress.

The Brekken laboratory, located in the Hamon Center for Therapeutic Oncology Research, studies tumor-host interactions with a particular emphasis on extracellular matrix (ECM) and angiogenesis.

The Bann Laboratory focuses on discovering novel mechanistic targets to treat heart failure. We aim to identify regulators of cardiac cell fate reprogramming and regeneration as a molecular strategy to repair and heal the heart following injury.